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Objective: To investigate the effects of recombinant (r-) LH supplementation in “low responder” patients
undergoing ovarian stimulation with r-FSH for an IVF program. The apoptosis rate in cumulus cells was used as
an indicator of oocyte quality.
Design: Comparison of the rate of DNA fragmentation and caspase-3 activity in cumulus cells in women
stimulated with r-LH and r-FSH, versus patients treated with r-FSH alone (control).
Setting: In vitro fertilization (IVF) laboratory.
Patient(s): Forty patients undergoing assisted fertilization programs treated with a GnRH agonist, or r-FSH
treatment begun on day 3 of the cycle (control). In the r-LH group, from day 8 of gonadotropin stimulation, 150
IU per day of r-LH were administered.
Intervention(s): Terminal deoxynucleotidyl transferase-mediated digoxigenin-deoxyuridine-triphosphate (dUTP)
nick-end labeling (TUNEL) assay, and anti-caspase-3 cleaved immunoassay, to detect apoptosis in human
cumulus cells.
Main Outcome Measure(s): Difference in DNA fragmentation rate between cumulus cells derived from r-LH
treatment and cumulus cells derived from control patients.
Result(s): No differences were observed between the two groups in the total amount of r-FSH administered and
in the number of retrieved oocytes per patient. A statistically significant increase in the number of immature
oocytes and in the E2 serum peak was observed in the control group. The number of transferred embryos was
significantly higher in the r-LH group. Pregnancy and implantation rates were higher in the r-LH group, but
without statistical significance. The apoptosis rate in cumulus cells was higher in the control group than in the
r-LH group.
Conclusion(s): This study suggests that supplementation with r-LH improves the chromatin quality of cumulus
cells involved in the control of oocyte maturation. (Fertil Steril 2007;87:542–6. ©2007 by American Society for
Reproductive Medicine.)
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aormally, functional ovarian activity involves the synergic
ction of the two pituitary gonadotropins, FSH and LH,
hich determine follicular growth and maturation, ovula-
ion, and luteinization. Their combined action on granulosa
ells, and on the internal theca, is expressed in the “two
ells-two gonadotrophins” theory (1). Years of experience in
nducing multiple follicular growth has shown that ovarian
ollicular growth proceeds normally in the presence of very
mall quantities of endogenous LH. In other words, endog-
nous LH is able, in the presence of pharmacological doses
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Copyright ©2007 American Society for Reproductive Medicine,f FSH, to allow adequate follicular steroidogenesis, even
hen present in very low serum concentrations, as it need be
ied only to1% of its receptors expressed by the theca cells
2).
Our interest was in investigating normogonadotropic
omen who, when undergoing induction of multiple follic-
lar growth, showed an insufficient ovarian response in
erms of follicular growth (defined as “low responders”),
espite an increase in the units of gonadotropin adminis-
ered. Hence, the administration of GnRH could completely
uppress the secretion of endogenous LH, without any ex-
genous support to maintain the biological activity of the
H. In this study, we tried to verify the efficiency of sup-
lementation with exogenous LH, during ovarian stimula-
ion, in those patients who had previously experienced failed
ttempts at assisted fertilization. The clinical effect was
ssessed in terms of ovarian response, and especially the
0015-0282/07/$32.00
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Fnfluence on the quality of oocytes that were collected. We
ried to identify indicators that were not the classic morpho-
ogical assessment criteria for oocyte quality, but sought
ather to establish better oocyte quality through chromatin
nalysis of the oophorous cumulus cells, which play a vital
ole in the maturation of oocytes during folliculogenesis.
ranulosa cells, as is well-known (3), are highly sensitive to
poptotic pathways, thus most follicles that are selected
uring the reproductive life of a woman are discarded by
tresia, an apoptotic process. The somatic cells of follicles
hat reach ovulation are supported by specific metabolic
athways that guarantee survival. Such pathways are acti-
ated by gonadotropins and by an as yet undefined number
f growth factors, which prevent an apoptotic outcome (4).
n the patients involved in this study, we verified whether the
dministration of LH during ovarian stimulation may have
onditioned the chromatin pattern of the oophorous cumulus
ells, considering this an important marker in defining ade-
uate biological activity that would allow optimum synchro-
ization of cytoplasmic and nuclear maturation of the oocyte.
ATERIALS AND METHODS
prospective and randomized study was performed with 60
atients (who had undergone previous stimulation of r-FSH
3,000 IU), from September 2004 to February 2005. On day
of stimulation, 42 patients were enrolled (Fig. 1), 24 of
hom were treated with r-FSH combined with r-LH, while
8 were stimulated with r-FSH and used as a control group.
andomization was realized in blocks of three, using com-
uter-generated random number tables. The sample size of
0 patients in each treatment group was calculated to have
0% power to detect a mean difference of 2.0, with a
ignificance level of 0.01. All patients who presented a
ormal basic level of FSH (12 IU/mL) and normal body
ass index (BMI  kg/m2 28) were treated with a GnRH
gonist (buserelin, 0.2 mL/d), starting on day 21 of the
revious cycle. The average age was 33.00 years in the LH
roup, and 36.33 years in the control group. Administration
FIGURE 1
Flow chart of studied patients.c
Ruvolo. Apoptosis in human cumulus cells. Fertil Steril 2007.
ertility and Sterilityf r-LH (75–150 IU/d, Luveris; Serono Pharma, Rome, Italy)
n the specific LH group began from day 8 after starting
-FSH stimulation. The stimulation therapy continued with a
xed daily dose of 225 IU of r-FSH (Gonal-F; Serono
harma, Rome, Italy). Follicular growth was monitored daily
sing ultrasound and serum Estradiol E2 levels starting on
ay 6 of stimulation, modifying the dose of r-FSH as a
onsequence. When, on day 8, patients presented a value of
erous E2 180 pg/mL, and the ovarian condition showed at
east six follicles with diameters ranging between 7–10 mm
nd no follicle with a diameter 12 mm, group randomiza-
ion was carried out in the two study groups. The ovulatory
ose of 10,000 IU of hCG (Gonasi; AMSA SRL, Rome,
taly) was administered when at least 3 or 4 follicles pre-
ented a diameter of 18 mm. Apoptosis in cumulus cells
as examined with the use of a terminal deoxynucleotidyl
ransferase-mediated dUTP nick-end labeling (TUNEL) as-
ay and the immunotest for caspase-3.
The pool of cumulus cells was collected after incubating
he cumulus-oocyte complex in a solution of hyaluronidase
80 IU/mL, Medicult, Jyllinge, Denmark). The released cells
ere collected in a test tube (Falcon, Franklin Lakes, NJ)
ontaining 2 mL of basic culture medium (Quinn’s advan-
age medium with HEPES; SAGE IVF, Trumbull, CT) and
entrifuged twice at 300  g for 10 minutes. Oocytes were
ransferred to a culture medium (fertilization medium, SAGE
VF) and incubated at 37°C, 5% CO2, until the moment of
arrying out intracytoplasmic sperm injection (ICSI).
Cumulus cells were then fixed in 3.7% paraformaldehyde
or 60 minutes. After centrifuging at 300  g for 5 minutes,
he supernatant was removed, and phosphate-buffered
aline (PBS)-glycine was added (0.1 M glycine in PBS
nd 0.3 mg/mL bovine serum albumin [BSA]). Then the
ells were mounted on polylysine-coated glass slides by
ytocentrifugation.
luorescent TUNEL Assay, or TdT In Situ
umulus cells were washed for 5 minutes in 1 PBS (137
M NaCl, 2.68 mM KC1, 1.47 mM KH2PO4, and 8.1 mM
a2HPO4) and permeated for 10 minutes on ice in 0.1%
riton X100 and 0.1% sodium-citrate in 1 PBS, and then
ashed three times in 1 PBS at room temperature for 5
inutes each time. Cumulus cells were then incubated for 60
inutes at 37°C in a humidified chamber in 50 L of a
ixture containing 5 L of nucleotide Mix, 1 L of TdT
nzyme, and 45 L of equilibration buffer (DeadEnd Flu-
rometric TUNEL System, Promega Italia SRL, Milano,
taly).
Cumulus cells were incubated with the same mixture
ithout the TdT enzyme (negative control), and another
lide was pretreated for 5 minutes with 100 L of DNAse
uffer, and then treated for 10 minutes with a DNAse buffer
olution containing 10 unit/mL of DNAse I (positive
ontrol).
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rReaction was blocked with 2 SSC for 15 minutes. Three
ashes of 5 minutes each were carried out in 1 PBS. Cumulus
ells were stained with propidium iodide (1 g/mL) for 10
inutes at room temperature,and observed under a fluores-
ent microscope equipped with a 20 0.40 objective.
nti-Caspase-3 Cleaved Immunoassay
fter three washes in 1 PBS (137 mM NaCl, 2.68 mM
Cl, 1.47 mM KH2PO4, and 8.1 mM NaH2PO4), cumulus
ells were permeated for 10 minutes on ice in 0.1% Triton
100 and 0.1% sodium-citrate in 1 PBS. Then after an-
ther three rinses with 1 PBS, cells were incubated over-
ight at 4°C with anti-caspase-3 cleaved polyclonal antibody
Cell Signaling Technology, Inc., Danvers, MA) (1:50 dilu-
ion) in 1 PBS containing 3% BSA. In negative controls,
he primary antibody was omitted. After three rinses with
BS, anti-rabbit Ig fluorescein-linked (Amersham Bio-
ciences, Milano, Italy) (1:60 dilution in 1 PBS containing
% BSA) secondary antibody was added to the samples for
0 minutes. Then the secondary antibody surplus was re-
oved by washing three times with PBS. Cumulus cells
ere stained with propidium iodide (1 g/mL) for 10 min-
tes. Slides were mounted in 10 L DABCO solution
deionized H2O, 1 M Tris-HCl, pH 8, 2 mM DABCO, and
lycerol) for maintaining fluorescence, and were observed
nder a confocal laser scanning microscope (Olympus
V300, Olympus Italia S.r.l. Segrate (MI)), equipped with
reen helium-neon (543-nm) and blue argon-ion (488-nm)
asers. Optical sections were captured using an PlanApo60
.40 oil objective.
tatistics
he data obtained in the treatment and control groups were
TABLE 1
Results of the trial between patients treated with
only with r-FSH (control group).
Variables Control gr
Cycles (n) 18
Age (average  SD) 36.33  2
FSH administered (IU) 3,644.4  1
E2 on day of hCG (pg/mL) 2,640.22  1
Recovered oocytes (n) 7.00  3
GV-MI oocytes (n) 2.33  2
Fertilization rate (%) 85.7
Embryos, grades 1–2 (n) 2.11  1
Transferred embryos (n) 1.56  1
Pregnancy rate (%) 25.0
Implantation rate (%) 12.5
Note: GV-MI, Germinal Vesicle-Metaphase I
Ruvolo. Apoptosis in human cumulus cells. Fertil Steril 2007.ompared using Student’s t-test and the chi-square test. All
544 Ruvolo et al. Apoptosis in human cumulus cellseported values are given as 95% confidence intervals.
.01 was considered statistically significant.
ESULTS
n this study, we used the procedures of our previous re-
earch to investigate apoptosis in human oocytes (5). A
UNEL assay and immunological tests, performed in situ
ith the anti-caspase-3 cleaved antibody, allowed us to
ighlight fragments of DNA and to confirm apoptosis,
espectively.
The results showed (Table 1) that there was no statistical
ifference between the two groups in terms of the quantity of
-FSH administered and the number of collected mature
ocytes. A significant statistical difference, however, was
ecorded in the number of immature oocytes collected (2.33
TABLE 2
TdT assay and caspase-3 immunoassay in
cumulus cells.
Study
group
Cells
(n)
Positive
TdT
(%)
Positive
caspase-3
immunoassay
(%)
Control
group
 SD
568  72 18.2 17.0
LH group
 SD
612  76.5 12.1 11.0
Note: TdT, terminal deoxynucleotidyl transferase
H and r-FSH (LH group) and patients treated
LH group P
24
33.00  3.1
0 3,731.2  1,773
1 1,228.00  830.59 .01
5.33  4.8
0.58  1.08 .01
74.6
2.82  0.4
2.91  0.5 .01
45.4 .01
15.6 .01r-L
oup
.1
,11
,22
.6Ruvolo. Apoptosis in human cumulus cells. Fertil Steril 2007.
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Fn the control group, versus 0.58 in the LH group; P.01), in
he quantity of estrogen at the time of induction of ovulation
2,640.22 Pgr/mL in the control group, versus 1,228.0
gr/mL in LH group; P.01), and in the number of embryos
ransferred, with the highest result in the LH group (2.91
ersus 1.56; P.01).
A significant difference was found in the LH group, where
higher pregnancy rate (PR) (45.4% vs. 25%) and implan-
ation rate (15.6% versus 12.5%) have been recorded in the
H group. The study of apoptosis in cumulus cells (Table 2)
howed a higher rate of cells with chromatin fragmentation
n the control group than in the LH group (TdT, 18.2%
ersus 12.1%). The higher presence of caspase-3 cleaved in
he control group than in the LH group (17.0% versus
1.0%) could be a sign of irreversible apoptosis. A similar
ate of caspase-3 cleaved and DNA fragmentation was found
n both groups.
ISCUSSION
his study focused on verifying whether the administration
f LH could increase PR and implantation rate by improving
he quality of oocytes collected after multiple follicular
rowth therapy.
The fundamental role of somatic cells in sustaining ade-
uate ovarian development has been recognized for many
ears. In 1935 (6), a close connection between the two types
f cells, granulosa cells and oocyte, was shown. It was also
emonstrated that oocytes collected from preantral follicles
pontaneously resume meiosis (gonadotropin-independent)
n culture, leading to the conclusion that somatic cells of the
umulus-oocyte complex (COC) keep the oocytes in a state
f meiotic arrest. Subsequent studies showed that somatic
ollicular cells promote meiotic resumption and its continu-
tion into metaphase II (nuclear maturation). Cumulus cells
lso promote the oocyte “ability” necessary for adequate
ertilization and the consecutive embryogenesis that ends
ith implantation (cytoplasmic maturation). Thus the main
ole of follicular somatic cells, especially during the final
hases of folliculogenesis, consists of synchronizing nuclear
aturation with cytoplasmic maturation through the com-
lete suppression of oocyte transcription until nuclear matu-
ity (7–9). Various investigators showed that close molecular
ommunication between oocytes and granulosa cells exists
uring folliculogenesis (hypothesis of an oocyte-granulosa
ell regulatory loop), essential for inducing and coordinating
ifferentiation in the oocyte and in the somatic compartment.
Several molecules are involved in this specific pathway:
ocyte growth differentiation factor 9 (10,11) seems to con-
rol the physiological syncronization of cytoplasmic and
uclear maturation (12,13). The mRNA of epidermal growth
actor (EGF) was also found in granulosa, cumulus, and
ocyte cells, and it acts on granulosa and cumulus cells
ith an antiapoptotic effect (14). Growth differentiationactor-9 synthesis is activated by EGF in the oocyte, with
ertility and Sterilitypositive effect on cumulus cells. The expression of EGF
eems to be induced by LH in the theca cells, and as a
olecular cascade it involves granulosa, cumulus, and
ocyte synthesis of EGF (15), preserving these cells from
poptotic destiny.
Our results seem to confirm this scenario. The data suggest
hat supplementation with r-LH during the late follicular phase
mproves some clinical parameters. In particular, it seems to
educe significantly the number of immature oocytes collected
fter pick-up, while it increases the number of embryos trans-
erred, correlated with a lower risk of hyperstimulation, as
hown in the lower value of the E2 plasmatic peak. Further-
ore, the increase in PR and implantation rate may be corre-
ated with the reduction of apoptosis seen in the cumulus cells
f patients treated with r-LH. This may represent a situation in
hich, although in the presence of a low quantity of this
ormone, because of its direct action on the cumulus and
ranulosa cells, or because of the paracrine effect mediated by
ecreting factors in the theca and oocyte cells, the cumulus cells
re preserved from apoptosis. Maintaining their physiological
unction for a longer time, cumulus cells are better able to
upport nuclear and cytoplasmatic maturation of the oocyte
ntil ovulation, thus allowing the collection of oocytes with
etter “intrinsic” qualities that are necessary for sustaining
ertilization and the early phases of embryogenesis. Hence, if
umulus cells are preserved from apoptotic processes, the oo-
yte of the COC receives no molecular signal able to activate
poptotic pathways.
Bosco et al. (5) demonstrated that apoptosis in human oo-
ytes determines fertilization failure after ICSI. If the activation
f apoptosis in the oocyte is regulated by molecular signals
oming from cumulus cells through gap-junctions, we consider
lower apoptotic rate in cumulus cells to be an indicator of
ood oocyte quality, in terms of a greater capacity to be fertil-
zed and to produce embryos with a higher implantation poten-
ial. Further studies will be necessary, especially in the area of
olecular communication between the various components of
he follicular unit, to provide further support for these data.
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